Cargando...
Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals
INTRODUCTION: The FDA issued a warning following 24 cases of HBV reactivation during DAA therapy for HCV, including individuals with inactive, occult and past HBV infection. Clinical presentations ranged from asymptomatic fluctuations in HBV DNA to fulminant hepatic failure, liver transplantation an...
Gardado en:
| Publicado en: | Expert Opin Drug Saf |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5589072/ https://ncbi.nlm.nih.gov/pubmed/28471314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1325869 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|